Cargando…
Fecal Calprotectin and Clinical Disease Activity in Pediatric Ulcerative Colitis
Objective. To explore fecal calprotectin levels in pediatric ulcerative colitis (UC) in relation with the validated clinical activity index PUCAI. Methods. This study included all 37 children (median age 14 years) with UC who had calprotectin measured (PhiCal ELISA Test) by the time of PUCAI assessm...
Autores principales: | Kolho, Kaija-Leena, Turner, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600299/ https://www.ncbi.nlm.nih.gov/pubmed/23533791 http://dx.doi.org/10.1155/2013/179024 |
Ejemplares similares
-
Fecal calprotectin in juvenile idiopathic arthritis patients related to drug use
por: Aalto, Kristiina, et al.
Publicado: (2017) -
Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis
por: Urushikubo, Jun, et al.
Publicado: (2018) -
Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis
por: Kim, Dong Ju, et al.
Publicado: (2018) -
Diagnostic Value of Fecal Calprotectin in Patient with Ulcerative Colitis
por: Zamani, Hamed, et al.
Publicado: (2013) -
Therapeutic Efficacy of pH-Dependent Release Formulation of Mesalazine on Active Ulcerative Colitis Resistant to Time-Dependent Release Formulation: Analysis of Fecal Calprotectin Concentration
por: Kawashima, Kousaku, et al.
Publicado: (2014)